US5739109A
(en)
*
|
1988-12-16 |
1998-04-14 |
Advanced Immunit Inc. |
Method of treating neuroinflammatory degenerative diseases
|
US20040208875A1
(en)
*
|
1995-03-15 |
2004-10-21 |
Queen's University At Kingston |
Method for treating amyloidosis
|
EP1060750B1
(de)
*
|
1993-03-29 |
2005-12-07 |
Queen's University At Kingston |
Propan-1,3-disulphonsäure und deren pharmazeutisch akzeptable Salze zur Behandlung von Amyloidosis
|
US5840746A
(en)
*
|
1993-06-24 |
1998-11-24 |
Merck Frosst Canada, Inc. |
Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
|
GB9314693D0
(en)
*
|
1993-07-15 |
1993-08-25 |
Smithkline Beecham Plc |
Naphthyl derivatives for treatment method
|
AU1891295A
(en)
*
|
1994-02-22 |
1995-09-04 |
Knoll Aktiengesellschaft |
Use of 1-(arylalkylaminoalkyl) imidazoles for treating neurological damage
|
US5643960A
(en)
*
|
1994-04-15 |
1997-07-01 |
Duke University |
Method of delaying onset of alzheimer's disease symptoms
|
US6025395A
(en)
|
1994-04-15 |
2000-02-15 |
Duke University |
Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders
|
WO1995031192A1
(en)
*
|
1994-05-16 |
1995-11-23 |
Thomas Jefferson University |
Method and use of agents to inhibit protein polymerization and methods of identifying these agents
|
US6160018A
(en)
*
|
1995-03-13 |
2000-12-12 |
Loma Linda University Medical Center |
Prophylactic composition and method for alzheimer's Disease
|
US5955504A
(en)
*
|
1995-03-13 |
1999-09-21 |
Loma Linda University Medical Center |
Colorectal chemoprotective composition and method of preventing colorectal cancer
|
US5981592A
(en)
*
|
1995-03-13 |
1999-11-09 |
Loma Linda University Medical Center |
Method and composition for treating cystic fibrosis
|
US7069634B1
(en)
|
1995-04-28 |
2006-07-04 |
Medtronic, Inc. |
Method for manufacturing a catheter
|
US5776946A
(en)
*
|
1995-08-28 |
1998-07-07 |
Mcgeer; Patrick L. |
Peripheral benzodiazepine receptor ligands as antiinflammatory agents
|
US5846220A
(en)
*
|
1996-04-30 |
1998-12-08 |
Medtronic, Inc. |
Therapeutic method for treatment of Alzheimer's disease
|
US7189222B2
(en)
|
1996-04-30 |
2007-03-13 |
Medtronic, Inc. |
Therapeutic method of treatment of alzheimer's disease
|
IT1282736B1
(it)
*
|
1996-05-21 |
1998-03-31 |
Angelini Ricerche Spa |
Uso di derivati del p-amminofenolo per preparare composizioni farmaceutiche utili nel trattamento di malattie neurodegenerative
|
WO1998002160A1
(en)
*
|
1996-07-11 |
1998-01-22 |
Warner-Lambert Company |
Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone
|
EP0927156A1
(de)
*
|
1996-09-04 |
1999-07-07 |
Warner-Lambert Company |
Biphenylbuttersäure und deren derivate als matrixmetalloproteinase inhibitoren
|
US6184248B1
(en)
|
1996-09-05 |
2001-02-06 |
Robert K. K. Lee |
Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
|
ITMI962356A1
(it)
*
|
1996-11-13 |
1998-05-13 |
Uni Degli Studi Di Brescia D I |
Uso di composti derivati da molecole ad attivita' antinfiammatoria di tipo non steroideo per la prevenzione e il trattamento di
|
US5994398A
(en)
*
|
1996-12-11 |
1999-11-30 |
Elan Pharmaceuticals, Inc. |
Arylsulfonamides as phospholipase A2 inhibitors
|
US5880116A
(en)
*
|
1996-12-13 |
1999-03-09 |
Neurocal International |
Use of celastrol to treat alzheimer's disease
|
AU5727798A
(en)
*
|
1996-12-23 |
1998-07-17 |
Texas A & M University, The |
Anti-amyloidogenic agents
|
US7071298B2
(en)
*
|
1997-02-05 |
2006-07-04 |
Fox Chase Cancer Center |
Compounds and methods for treating glycogen storage disease and other pathological conditions resulting from formation of age-proteins
|
DK0966277T3
(da)
*
|
1997-03-10 |
2006-03-27 |
Univ Loma Linda Med |
Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom
|
EP1006794B1
(de)
|
1997-03-12 |
2007-11-28 |
Robert W. Esmond |
Verfahren zur behandlung oder prävention der alzheimerischen krankheit
|
US7790856B2
(en)
*
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
US6743427B1
(en)
|
1997-12-02 |
2004-06-01 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
US6710226B1
(en)
|
1997-12-02 |
2004-03-23 |
Neuralab Limited |
Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics
|
TWI239847B
(en)
*
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US6923964B1
(en)
|
1997-12-02 |
2005-08-02 |
Neuralab Limited |
Active immunization of AScr for prion disorders
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
US6761888B1
(en)
*
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
US20080050367A1
(en)
*
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
US7179892B2
(en)
*
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
US6913745B1
(en)
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
US6787523B1
(en)
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
US6750324B1
(en)
|
1997-12-02 |
2004-06-15 |
Neuralab Limited |
Humanized and chimeric N-terminal amyloid beta-antibodies
|
US7588766B1
(en)
|
2000-05-26 |
2009-09-15 |
Elan Pharma International Limited |
Treatment of amyloidogenic disease
|
US20020022657A1
(en)
*
|
1998-02-11 |
2002-02-21 |
Francine Gervais |
Methods for modulating neuronal cell death
|
US20050059802A1
(en)
*
|
1998-04-07 |
2005-03-17 |
Neuralab Ltd |
Prevention and treatment of amyloidogenic disease
|
US20030147882A1
(en)
*
|
1998-05-21 |
2003-08-07 |
Alan Solomon |
Methods for amyloid removal using anti-amyloid antibodies
|
WO2000012093A1
(en)
|
1998-08-31 |
2000-03-09 |
Merck & Co., Inc. |
Method of treating neurodegenerative diseases
|
US6191154B1
(en)
*
|
1998-11-27 |
2001-02-20 |
Case Western Reserve University |
Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
|
DE60042896D1
(de)
*
|
1999-04-28 |
2009-10-15 |
Bellus Health Int Ltd |
Zusammensetzungen und verfahren zur behandlung von amyloidosis mit sulphonatderivaten
|
US6787637B1
(en)
|
1999-05-28 |
2004-09-07 |
Neuralab Limited |
N-Terminal amyloid-β antibodies
|
UA81216C2
(en)
*
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
US6541521B1
(en)
|
1999-07-12 |
2003-04-01 |
Warner-Lambert Company |
Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases
|
DE60028787T2
(de)
*
|
1999-08-10 |
2007-06-06 |
Uab Research Foundation, Birmingham |
Methode zur behandlung von verletzungen des traumatisierten gehirns mit nicht-steroid entzündungshemmenden medikamenten
|
US20060004086A1
(en)
*
|
2000-04-13 |
2006-01-05 |
Mayo Foundation For Medical Education And Research |
Method of reducing Abeta42 and treating diseases
|
AU5702201A
(en)
*
|
2000-04-13 |
2001-10-30 |
Mayo Foundation |
Abeta<sub>42</sub> lowering agents
|
US20080021085A1
(en)
*
|
2000-04-13 |
2008-01-24 |
Mayo Foundation For Medical Education And Research |
Method of reducing abeta42 and treating diseases
|
AU2001283528A1
(en)
*
|
2000-07-31 |
2002-02-13 |
Neuronautics, Inc. |
Improved methods for identifying reagents which inhibit tau polymerization
|
PE20020574A1
(es)
*
|
2000-12-06 |
2002-07-02 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido amiloideo beta
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
ITMI20010985A1
(it)
*
|
2001-05-15 |
2002-11-15 |
Nicox Sa |
Farmaci per il morbo di alzheimer
|
JP4865958B2
(ja)
*
|
2001-05-23 |
2012-02-01 |
株式会社トクホン |
鎮痛抗炎症局所作用型の貼付剤
|
US20040132823A1
(en)
*
|
2001-11-02 |
2004-07-08 |
Leo Pavliv |
Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
|
US20030106829A1
(en)
*
|
2001-12-07 |
2003-06-12 |
Costello Anthony William |
Slotted overwrapped tray
|
MY139983A
(en)
*
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
JP4743382B2
(ja)
|
2002-06-06 |
2011-08-10 |
株式会社医薬分子設計研究所 |
O−置換ヒドロキシアリール誘導体
|
TWI280127B
(en)
*
|
2002-06-11 |
2007-05-01 |
Inst Med Molecular Design Inc |
Remedies for neurodegenerative diseases
|
TW200413009A
(en)
*
|
2002-10-04 |
2004-08-01 |
Univ Pennsylvania |
Biphenyls and fluorenes as imaging agents in alzheimer's disease
|
JP2006516639A
(ja)
*
|
2003-02-01 |
2006-07-06 |
ニユーララブ・リミテツド |
可溶性A−βに対する抗体を生成させるための能動免疫
|
EP1603548A4
(de)
*
|
2003-02-05 |
2007-10-10 |
Myriad Genetics Inc |
Verfahren und zusammensetzung zur behandlung neurodegenerativer erkrankungen
|
AT413944B
(de)
*
|
2003-05-27 |
2006-07-15 |
Binder Eva Dkfm |
Verwendung von oxicam-verbindungen
|
CA2527114A1
(en)
*
|
2003-05-30 |
2004-12-16 |
Microbia, Inc. |
Methods for the protection of memory and cognition
|
PE20050627A1
(es)
|
2003-05-30 |
2005-08-10 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido beta amiloideo
|
US7414076B2
(en)
|
2003-06-23 |
2008-08-19 |
Neurochem (International) Limited |
Methods and compositions for treating amyloid-related diseases
|
US20070010573A1
(en)
*
|
2003-06-23 |
2007-01-11 |
Xianqi Kong |
Methods and compositions for treating amyloid-related diseases
|
US7244764B2
(en)
*
|
2003-06-23 |
2007-07-17 |
Neurochem (International) Limited |
Methods and compositions for treating amyloid-related diseases
|
AU2004311577A1
(en)
*
|
2003-07-11 |
2005-07-21 |
Myriad Genetics, Inc. |
Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
|
US20050171207A1
(en)
*
|
2003-09-26 |
2005-08-04 |
Myriad Genetics, Incorporated |
Method and composition for combination treatment of neurodegenerative disorders
|
DE60336934D1
(de)
*
|
2003-10-03 |
2011-06-09 |
Veijlen N V |
Verwendung von igf-1-serumspiegel-erhöhenden indolessigsäure-derivaten zur herstellung eines arzneimittels zur behandlung von verschiedenen krankheiten
|
US20090155903A1
(en)
*
|
2004-03-19 |
2009-06-18 |
Myriad Genetics, Incorporated |
Pharmaceutical composition and method
|
US20070293538A1
(en)
*
|
2004-04-13 |
2007-12-20 |
Myriad Genetics, Incorporated |
Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
|
WO2005108683A1
(en)
*
|
2004-04-29 |
2005-11-17 |
Keystone Retaining Wall Systems, Inc. |
Veneers for walls, retaining walls and the like
|
WO2006020852A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
WO2006020850A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
WO2006020853A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
US20060183800A1
(en)
*
|
2004-11-12 |
2006-08-17 |
Xianqi Kong |
Methods and fluorinated compositions for treating amyloid-related diseases
|
US20060167057A1
(en)
*
|
2004-11-16 |
2006-07-27 |
Xianqi Kong |
Compounds for the treatment of CNS and amyloid associated diseases
|
PE20061329A1
(es)
*
|
2004-12-15 |
2006-12-08 |
Neuralab Ltd |
Anticuerpos ab humanizados para mejorar la cognicion
|
WO2006066049A2
(en)
*
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
JP2008524247A
(ja)
*
|
2004-12-15 |
2008-07-10 |
エラン ファーマ インターナショナル リミテッド |
認知の改善における使用のためのアミロイドβ抗体
|
CA2592320C
(en)
*
|
2004-12-22 |
2015-11-24 |
Neurochem (International) Limited |
Methods and compositions for treating amyloid-related diseases
|
TW200716088A
(en)
*
|
2005-04-15 |
2007-05-01 |
Neurochem Int Ltd |
Formulations and methods for treating amyloidosis
|
US20060293218A1
(en)
*
|
2005-06-22 |
2006-12-28 |
Meythaler Jay M |
Salicylate therapeutic compound and process for controlled delivery thereof
|
BRPI0613611A2
(pt)
*
|
2005-07-22 |
2011-01-18 |
Myriad Genetics Inc |
formulações de alta concentração de fármaco e formas de dosagens
|
ES2352801T3
(es)
*
|
2005-12-22 |
2011-02-23 |
Kiacta Sàrl |
Tratamiento de nefropatía diabética.
|
US8784810B2
(en)
*
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
EP2046119A2
(de)
*
|
2006-07-07 |
2009-04-15 |
Myriad Genetics, Inc. |
Behandlung von psychiatrischen störungen
|
US20090238763A1
(en)
|
2006-07-09 |
2009-09-24 |
Chongxi Yu |
High penetration compositions and uses thereof
|
US20090221703A1
(en)
|
2006-07-09 |
2009-09-03 |
Chongxi Yu |
High penetration composition and uses thereof
|
HUE028425T2
(en)
|
2006-08-08 |
2016-12-28 |
Techfields Biochem Co Ltd |
Positive charged water-soluble prodrugs of aryl and heteroarylacetic acids with very fast skin penetration rate
|
US10004703B2
(en)
|
2006-10-12 |
2018-06-26 |
Biogen Chesapeake Llc |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA++ activated ATP-sensitive cation channels regulated by SUR1 channels
|
US20100056444A1
(en)
|
2006-10-12 |
2010-03-04 |
Sven Martin Jacobson |
Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non Selective Ca Activated ATP- Sensitive Cation Channels Regulated by SUR1 Receptors
|
CA2666246C
(en)
|
2006-10-12 |
2013-12-31 |
Bellus Health (International) Limited |
Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
|
MX2009006768A
(es)
*
|
2006-12-22 |
2009-08-31 |
Bellus Health Int Ltd |
Metodos, compuestos, y composiciones para tratar trastornos metabolicos y diabetes.
|
WO2008124585A1
(en)
*
|
2007-04-06 |
2008-10-16 |
Board Of Governors For Higher Education, State Of Rhode Island And Providence Planations |
Lowering of proteins associated with alzheimer's disease by interrupting gene transcription with a small molecule
|
CA2684323A1
(en)
*
|
2007-04-18 |
2008-10-30 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of cerebral amyloid angiopathy
|
US8003097B2
(en)
*
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
KR20150058566A
(ko)
*
|
2007-06-04 |
2015-05-28 |
테크필즈 인크 |
매우 높은 피부 및 막 침투율을 가지는 nsaia 약물전구체 및 이들의 새로운 의약적 용도
|
PL2182983T3
(pl)
|
2007-07-27 |
2014-10-31 |
Janssen Alzheimer Immunotherap |
Leczenie chorób amyloidowych z wykorzystaniem humanizowanych przeciwciał specyficznych względem Abeta
|
JO3076B1
(ar)
*
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
KR20210123406A
(ko)
|
2008-12-04 |
2021-10-13 |
충시 위 |
고투과력을 가진 조성물 및 이의 적용
|
JP6228302B2
(ja)
|
2013-07-11 |
2017-11-08 |
ユニバーシティー オブ ノース テキサス ヘルス サイエンス センター アット フォートワースUniversity Of North Texas Health Science Center At Fort Worth |
プライマリーケアセッティングにおいて神経学的疾患を検出するための血液に基づくスクリーニング
|
JP6364488B2
(ja)
|
2013-11-26 |
2018-07-25 |
ユニバーシティー オブ ノース テキサス ヘルス サイエンス センター アット フォートワースUniversity Of North Texas Health Science Center At Fort Worth |
認知欠損を治療するための個別化医療的手法
|
US20170143681A1
(en)
|
2015-11-02 |
2017-05-25 |
Apkarian Technologies Llc |
Methods and compositions for treating pain
|